Corsera Health aims to lead the future of medicine by extending healthspan through cardiovascular disease prediction and prevention. Co-founded by industry pioneers in RNAi therapeutics and cardiovascular medicine, the company is combining decades of innovation in RNAi therapeutics with world-leading expertise in cardiovascular disease prediction, efficient manufacturing and evidence generation, and disruptive commercialization. Corsera Health is headquartered in Boston, Mass.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/07/26 | $80,000,000 | Series A |
Forbion Capital Partners John Maraganore Population Health Partners | undisclosed |
